Investment
Features
FeesSafety
Academy
More
Pluang+

Compare First Trust NASDAQ Clean Edge Green Energy Idx Fd (QCLN) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance

First Trust NASDAQ Clean Edge Green Energy Idx FdTrade
Relay Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

First Trust NASDAQ Clean Edge Green Energy Idx Fd vs Relay Therapeutics Inc. Common Stock — how do they compare? First Trust NASDAQ Clean Edge Green Energy Idx Fd trades at $48.35 (market cap $561.25M), while Relay Therapeutics Inc. Common Stock trades at $17.88 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 6.8× First Trust NASDAQ Clean Edge Green Energy Idx Fd's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, First Trust NASDAQ Clean Edge Green Energy Idx Fd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold First Trust NASDAQ Clean Edge Green Energy Idx Fd for 50 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.

QCLNRLAY
Market Cap
$561.25M$3.82B
Volume
323,5504,332,079
Sector
Sector/ThematicHealth
52-Week High
$68.47$20.75
52-Week Low
$41.10$6.03
Typical Hold Time
50 Days0 Days
Enterprise Value
—$2.93B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

First Trust NASDAQ Clean Edge Green Energy Idx Fd

QCLN trades at $48.35, down 2.2% today, with technical indicators showing a bullish moving average signal but neutral oscillators. The ETF's performance is heavily influenced by U.S. clean energy policy and geopolitical developments, with recent news highlighting global renewable energy acceleration amid tensions. Support and resistance levels cluster around $50-$52, indicating a key price zone for near-term direction.

The outlook for QCLN hinges on political support for clean energy and rising electricity demand, offering growth potential but facing volatility from policy shifts. Risks include regulatory uncertainty and competitive pressures, while analyst sentiment remains watchful amid evolving market dynamics.

Relay Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QCLN

No sentiment data available yet.

RLAY
100% Buy0% Sell
Avg holding period · 0 Days

About First Trust NASDAQ Clean Edge Green Energy Idx Fd

QCLN invests in U.S.-listed companies engaged in clean energy technologies. It focuses on solar power, wind, electric vehicles, and energy storage, with major holdings in firms like Tesla, ON Semiconductor, and Rivian.

Read more on QCLN →

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →